Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alentis Therapeutics
Biotech
BridgeBio, Ipsen, George Medicines and more—Chutes & Ladders
BridgeBio spins out oncology company. Ipsen names new North America chief. George Medicines taps ex-Ironwood CEO for same role.
Max Bayer
,
Gabrielle Masson
May 3, 2024 8:30am
BIO announces new CEO—Chutes & Ladders
Dec 8, 2023 9:30am
Alentis secures $105M series C for anti-fibrotic ambitions
Apr 13, 2023 1:00am
New year, new C-suite execs—Chutes & Ladders
Jan 6, 2023 9:30am
Biogen CEO steps down after Aduhelm blunder—Chutes & Ladders
May 6, 2022 9:30am
Sanofi-backed Jeito snags $630M fund for 12-15 European biotechs
Sep 20, 2021 1:00am
